EMF Disturbance Monitors, Inc. is beginning our planned FDA Phase II human trial to determine whether our patented technology can accurately diagnose advanced congestive heart failure in adult humans. We are awaiting approval from clinicaltrials.gov to begin enrolling patients in the CONTROL arm of our study.
CREATING A NEW MEDICAL TEST
EMF Disturbance Monitors has developed a new medical test The test is based on electromagnetic field disturbance theory which was first pioneered by our Founder, Dr. Paul Browne, in 2009.
Think of our test like checking the charge on your car battery. A strong charge operates all of the electrical devices on your car. A weak charge may operate some of the devices but not the ignition. A very weak charge may not operate your car at all.
EMF Disturbance Theory hypothesizes that human organs have a resting “charge” just like a battery. Many human diseases are caused by decreased cellular energy production such as congestive heart failure, cardiomyopathy, traumatic brain injury (TBI), severe depression and dementia. These diseases can be difficult to diagnose using current technology. This can result in a delay in diagnosis and increases the risk of irreversible loss of heart or brain cells.
Our solution is designed to estimate the “charge” of your heart or brain using EMF Disturbance. Our test is brief and non-invasive. Early diagnosis of diseases improves patient outcome. We hope to revolutionize the screening process for many diseases that result from low cellular energy production.